Gerber Scientific Announces Fiscal 2008 Fourth Quarter and Full Year Results

SOUTH WINDSOR, CT - June 19, 2008 - Gerber Scientific, Inc. (NYSE: GRB) today reported net income for the quarter ended April 30, 2008 of $6.1 million, or $0.26 per diluted share, on revenue of $173.7 million, compared with net income of $5.6 million, or $0.24 per diluted share, on revenue of $155.1 million for the fourth quarter ended April 30, 2007. A decline in the exchange rates of the US dollar to other currencies had the effect of increasing revenue by approximately $12.9 million in the fourth quarter of fiscal 2008 as compared with the fourth quarter of fiscal 2007.

For the fiscal year ended April 30, 2008, the Company reported net income of $14.5 million, or $0.61 per diluted share, on revenue of $640.0 million. For the fiscal year ended April 30, 2007, the Company reported net income of $13.5 million, or $0.58 per diluted share, on revenue of $574.8 million. A decline in the exchange rates of the US dollar to other currencies had the effect of increasing revenue by approximately $37.1 million for the year ended April 30, 2008 as compared with the year ended April 30, 2007.

The Company generated $1.6 million in cash flows provided by operations, less capital expenditures, for fiscal 2008 as compared with a cash usage of $3.7 million in fiscal 2007.

Gerber Scientific President and Chief Executive Officer, Marc T. Giles, commented, "Gerber delivered solid fourth quarter and full year fiscal 2008 financial results, growing both revenue and earnings from the prior year. Excluding the favorable impact of foreign currency translation, revenue growth was driven by strong organic growth in our Spandex distribution business, success of new products, our acquisition of Data Technology and continued expansion in Asia. We were able to improve our business performance despite some key new product delays, most notably the Solara ion™, not fully achieving our expected targeted cost reductions through lean initiatives and challenging market conditions particularly in the Ophthalmic segment.”

Giles continued, “Looking ahead, although global economic uncertainty is evident, we currently expect significant growth in both revenue and profitability in fiscal year 2009. We expect this growth to be achieved through the anticipated success of the recently commercialized Solara ion and other new products, as well as gaining momentum and traction against our manufacturing cost reduction initiatives through the execution of lean principles under the direction of our new leadership in this area.”

About Gerber Scientific, Inc.
Gerber Scientific, Inc. (http://www.gerberscientific.com) is a leading international supplier of sophisticated automated manufacturing systems for the sign making and specialty graphics, apparel and flexible materials, ophthalmic lens processing, and print and packaging industries. Headquartered in South Windsor, Connecticut, the Company operates through four primary business units: Gerber Scientific Products, Spandex, Gerber Technology and Gerber Coburn.

Cautionary Note Concerning Factors That May Affect Future Results
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements contained in this news release regarding the Company's expected financial condition, results of operations, cash flows and product launches are forward-looking statements that involve risks and uncertainties. For information identifying other important economic, political, regulatory, legal, technological, competitive and other risks and uncertainties, readers are referred to the Company's filings with the Securities and Exchange Commission, including but not limited to, the information included in Gerber Scientific's Annual Report on Form 10-K for the fiscal year ended April 30, 2007 under the headings "Business," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations – Cautionary Note Concerning Factors That May Influence Future Results," as well as information included in subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K, which outline certain important risks regarding the Company's forward-looking statements. These risks include, but are not limited to, delays in the Company's new product development and commercialization, intense competition in markets for each of the Company's operating segments, rapid technological advances, availability and cost of raw materials, volatility in foreign currency exchange rates and fluctuations in interest rates. Actual future results or events may differ materially from those expressed or implied in the Company's forward-looking statements. The Company expressly disclaims any obligation to update any of these forward-looking statements, except as required by law.